Is Abingdon Health Plc (ABDXF) a Buy, Sell, or Hold?
OTC : ABDXF
Abingdon Health Plc
$0.13158 USD
$0.0 (-0.75%)
- Volume
- 5K
- Average Volume
- 9.96K
- Market Capitalization
- $24.94M
- P/E Ratio
- -11.61
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.21
- Year Low
- $0.07
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
Company Overview
OTC
Christopher William Hand
Medical - Diagnostics & Research
Healthcare
ABDXF
129
GB
USD
Liquidity Metrics
0.15
1.91
1.73
1.06
0.00
Sales & Valuation
$8.43M
1.97
6.11
-7.29
-0.01
Profitability
-$0.0093
-$3.42M
-33.88%
-33.02%
-55.91%
-30.73%
P/E Metrics
-11.61
0.53
0.53
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-2.02
5/9
$3.2M
$10.55M
$4.25M
-$6.41M
Key Metrics (TTM)
$16.6M
1.73
-5.58
1.91
-55.91%
-59.58%
-8.21%
-13.37%
-59 days
Company Executives
| Name | Title |
|---|---|
| Chris Henry Francis Yates | President of & Director Abingdon Health USA Inc. |
| Thomas Edward Hayes | Secretary, Chief Financial Officer & Director |
| Nina Garrett | Chief Technical Officer |
| Christopher William Hand | Executive Chairman |
| Mark Jones | Chief Operating Officer |
| Laura Towse | Controller |
Poll Results
No votes yet today — be the first to share your view!
About Abingdon Health Plc (OTC:ABDXF) Stock
Abingdon Health Plc is a global enterprise dedicated to the innovation, production, and worldwide distribution of diagnostic technologies. Their diverse product portfolio includes rapid self-diagnostic tools like the AbC-19 Rapid Test for detecting COVID-19 IgG antibodies and the 2019-nCoV Antigen Test for identifying SARS-CoV-2 antigens. They also offer a range of nucleic acid lateral flow immunoassays, including the PCRD and PCRD FLEX systems, which provide quick readouts following isothermal amplification. The 'Abingdon Simply Test' line further expands their selection of consumer-friendly self-tests. Beyond physical tests, Abingdon Health provides AppDx, an innovative, customizable image-capturing technology that essentially transforms any smartphone into a self-contained lateral flow ... reader. The company also extends its expertise through a variety of services, including contract manufacturing, bespoke nucleic acid lateral flow test customization, and comprehensive lateral flow development and production. Additionally, they offer strategic consultancy to businesses operating within the healthcare technology sector. Notably, Abingdon Health Plc maintains a significant collaboration and co-marketing agreement with Abcam plc. Founded in 2008, the company's operations are centrally managed from its headquarters in York, United Kingdom.
Abingdon Health plc to Present at the Life Sciences Investor Forum on June 25th
2026-06-18 08:35:00
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorConferences.com
Abingdon Health plc to Present at the Small Cap Growth Virtual Investor Conference June 4th
2026-06-03 12:20:00
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Frequently Asked Questions
-
What is the current Abingdon Health Plc (ABDXF) stock price?
-
Abingdon Health Plc(OTC:ABDXF) stock price is $0.13158 in the last trading session. During the trading session, ABDXF stock reached the peak price of $0.209 while $0.07 was the lowest point it dropped to. The percentage change in ABDXF stock occurred in the recent session was --0.75% while the dollar amount for the price change in ABDXF stock was -$0.0.
-
ABDXF's industry and sector of operation?
-
The OTC listed ABDXF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of ABDXF?
-
Chris Henry Francis Yates | President of & Director Abingdon Health USA Inc.
Thomas Edward Hayes | Secretary, Chief Financial Officer & Director
Nina Garrett | Chief Technical Officer
Christopher William Hand | Executive Chairman
Mark Jones | Chief Operating Officer -
How many employees does ABDXF have?
-
Number of ABDXF employees currently stands at 129. ABDXF operates from York Biotech Campus, York, YK YO41 1LZ, GB.
-
Link for ABDXF official website?
-
Official Website of ABDXF is: https://www.abingdonhealth.com
-
How do I contact ABDXF?
-
ABDXF could be contacted at phone #44 19 0440 6050 and can also be accessed through its website. ABDXF operates from York Biotech Campus, York, YK YO41 1LZ, GB.
-
How many shares of ABDXF are traded daily?
-
The average number of ABDXF shares traded daily for last 3 months was 9.96K.
-
What is the market cap of ABDXF currently?
-
The market value of ABDXF currently stands at $24.94M with its latest stock price at $0.13158